Walleye Capital’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.21M Sell
29,300
-38,500
-57% -$5.48M 0.01% 1095
2025
Q4
$11.3M Sell
67,800
-3,600
-5% -$602K 0.03% 578
2025
Q3
$14M Buy
71,400
+10,500
+17% +$1.73M 0.05% 396
2025
Q2
$5.51M Buy
60,900
+60,700
+30,350% +$4.8M 0.02% 821
2025
Q1
$11.9K Sell
200
-2,800
-93% -$259K ﹤0.01% 4055
2024
Q4
$397K Buy
3,000
+2,200
+275% +$206K ﹤0.01% 3179
2024
Q3
$41.9K Buy
+800
New +$37.5K ﹤0.01% 4681

Other funds holding ALAB

Walleye Capital's ALAB Position: Q1 2026 in Review

Walleye Capital reduced its Astera Labs (ALAB) stake by 44% in Q1 2026, selling an estimated $3.22M and leaving 28,814 shares worth $3.16M. The position accounts for 0.01% of the portfolio, ranked #1104.

Walleye Capital first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $19.8M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Walleye Capital held 28,814 shares of Astera Labs worth $3.16M as of Q1 2026.
  • Walleye Capital sold 22,618 Astera Labs shares in Q1 2026, an estimated $3.22M.
  • Astera Labs made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1104 holding.
  • Walleye Capital first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
  • Walleye Capital's Astera Labs position peaked at $19.8M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.